Kim WJ - Search Results

1

GSTT1-null genotype is a protective factor against bladder cancer.

Kim WJ, Kim H, Kim CH, Lee MS, Oh BR, Lee HM, Katoh T. Kim WJ, et al. Among authors: kim h, kim ch. Urology. 2002 Nov;60(5):913-8. doi: 10.1016/s0090-4295(02)01892-7. Urology. 2002. PMID: 12429337

2

Estrogen induction of smooth muscle differentiation of human prostatic stromal cells is mediated by transforming growth factor-beta.

Hong JH, Song C, Shin Y, Kim H, Cho SP, Kim WJ, Ahn H. Hong JH, et al. Among authors: kim h, kim wj. J Urol. 2004 May;171(5):1965-9. doi: 10.1097/01.ju.0000123064.78663.2c. J Urol. 2004. PMID: 15076322

3

Association of bladder tumors and GA genotype of -308 nucleotide in tumor necrosis factor-alpha promoter with greater tumor necrosis factor-alpha expression.

Jeong P, Kim EJ, Kim EG, Byun SS, Kim CS, Kim WJ. Jeong P, et al. Among authors: kim cs, kim eg, kim wj, kim ej. Urology. 2004 Nov;64(5):1052-6. doi: 10.1016/j.urology.2004.06.018. Urology. 2004. PMID: 15533517

4

Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer.

Kim EJ, Jeong P, Quan C, Kim J, Bae SC, Yoon SJ, Kang JW, Lee SC, Jun Wee J, Kim WJ. Kim EJ, et al. Among authors: kim wj, kim j. Urology. 2005 Jan;65(1):70-5. doi: 10.1016/j.urology.2004.08.005. Urology. 2005. PMID: 15667866

5

Genetic and epigenetic aspects of bladder cancer.

Kim WJ, Quan C. Kim WJ, et al. J Cell Biochem. 2005 May 1;95(1):24-33. doi: 10.1002/jcb.20412. J Cell Biochem. 2005. PMID: 15759278 Review.

6

Enhanced expression of peroxiredoxin I and VI correlates with development, recurrence and progression of human bladder cancer.

Quan C, Cha EJ, Lee HL, Han KH, Lee KM, Kim WJ. Quan C, et al. Among authors: kim wj. J Urol. 2006 Apr;175(4):1512-6. doi: 10.1016/S0022-5347(05)00659-2. J Urol. 2006. PMID: 16516038

7

Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence.

Lee SC, Kim YJ, Kim TH, Yun SJ, Lee NK, Kim WJ. Lee SC, et al. Among authors: kim yj, kim wj, kim th. J Urol. 2008 Feb;179(2):570-4. doi: 10.1016/j.juro.2007.09.040. Epub 2007 Dec 21. J Urol. 2008. PMID: 18078957

8

Molecular biomarkers in urothelial bladder cancer.

Kim WJ, Bae SC. Kim WJ, et al. Cancer Sci. 2008 Apr;99(4):646-52. doi: 10.1111/j.1349-7006.2008.00735.x. Cancer Sci. 2008. PMID: 18377416 Free PMC article. Review.

9

Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.

Kim EJ, Kim YJ, Jeong P, Ha YS, Bae SC, Kim WJ. Kim EJ, et al. Among authors: kim yj, kim wj. J Urol. 2008 Sep;180(3):1141-5. doi: 10.1016/j.juro.2008.05.002. Epub 2008 Jul 18. J Urol. 2008. PMID: 18639281

10

Epigenetic markers as promising prognosticators for bladder cancer.

Kim YK, Kim WJ. Kim YK, et al. Among authors: kim wj. Int J Urol. 2009 Jan;16(1):17-22. doi: 10.1111/j.1442-2042.2008.02143.x. Epub 2008 Aug 20. Int J Urol. 2009. PMID: 18721202 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,098 results

Search Page

Filters